Speedinvest is a European venture capital firm that invests from pre-seed through growth stages, with dedicated practices spanning Fintech, DeFi, AI, and infrastructure. Speedinvest's Twitter Score is 7.9 out of 1000 as of July 2026, ranking #127,403 among 531,432 tracked accounts.
Speedinvest was founded by Oliver Holle, who serves as Founder, CEO, and Managing Partner. The firm operates as Speedinvest GmbH, an Austrian limited-liability company licensed as an Alternative Investment Fund Manager under Austria's AIFMG. In December 2022, Speedinvest announced €500 million in new capital, comprising €300 million for Speedinvest 4 and the remainder allocated to follow-on co-investments. As of March 2026, the firm managed more than €1.2 billion across more than 400 portfolio companies.
Speedinvest's Fintech and DeFi practice covers digital assets, Web3, and stablecoin infrastructure, with Bitpanda among its portfolio spotlights. The firm has also published the Crypto 50 EMEA, an independent market map of privately held crypto companies across the EMEA region. Speedinvest is backed by New Enterprise Associates, the European Investment Fund, Bpifrance, Generali, and Aviva. The firm maintains a strategic joint-venture partnership with SBI Ventures Europe and collaborates with the Qatar Investment Authority through its Fund of Funds program. Molten Ventures serves as lead investor in a continuation vehicle alongside Acurio Ventures, with Ion Pacific as a continuation-vehicle collaborator.
Speedinvest's fund portfolio includes Bitpanda, Molecule, Octav, Ultimate Wallet, Flowdesk, One Trading, Bitpanda and EXA Market. Speedinvest has published 3,773 posts on the platform and has been mentioned by 110 accounts a total of 299 times, reflecting consistent engagement across the crypto and venture capital community.
Who follows Speedinvest on X?
The accounts that follow Speedinvest include 55 founders, 5 angel investors, 12 influencers and 34 VCs. Among the most prominent followers are Matthew Graham, VCs Congratulating Themselves, Wong Joon Ian, David Haber, Paul Kohlhaas Bioacc and Randi Zuckerberg.